US 11,896,042 B2
Ribonucleotide-rich yeast extract and use of same for masking undesirable flavours and undesirable aromatic notes
Hélène Jolivet, Vincennes (FR); Rudy Menin, Choisy le Roi (FR); and Antoine Thomas, Paris (FR)
Assigned to LESAFFRE ET COMPAGNIE, Paris (FR)
Appl. No. 16/772,388
Filed by LESAFFRE ET COMPAGNIE, Paris (FR)
PCT Filed Nov. 12, 2018, PCT No. PCT/FR2018/052808
§ 371(c)(1), (2) Date Jun. 12, 2020,
PCT Pub. No. WO2019/115894, PCT Pub. Date Jun. 20, 2019.
Claims priority of application No. 17 62074 (FR), filed on Dec. 13, 2017.
Prior Publication US 2021/0076722 A1, Mar. 18, 2021
Int. Cl. A23L 31/15 (2016.01); A23L 27/28 (2016.01); A23L 27/23 (2016.01); C12N 1/18 (2006.01); A23L 27/00 (2016.01)
CPC A23L 31/15 (2016.08) [A23L 27/23 (2016.08); A23L 27/28 (2016.08); A23L 27/86 (2016.08); C12N 1/18 (2013.01)] 15 Claims
 
1. A 5′-ribonucleotide-rich yeast extract comprising from 25 to 55 wt % 5′-ribonucleotides, wherein the yeast extract comprises 5 to 20 wt % 5′-AMP and 5 to 20 wt % 5′-GMP, in a 5′-AMP/5′-GMP ratio of between 0.85 and 1.25, the weight percentages being based on the dry weight of the yeast extract.